The medications currently available for the treatment of Alzheimer's include cholinesterase inhibitors, memantine. Mood stabilizers, on the other hand, are medications that have been designed to help patients with variable emotions (Klimova et al., 2015). Studies have supported the use of mood stabilizers in conditions such as dementia, a condition that results from Alzheimer's disease. However, physicians usually take into account several factors when prescribing such medications for patients with Alzheimer's disease. Lithium is mainly used in the treatment of bipolar, but several studies have also shown the effectiveness of this medication I challenging behaviors in dementia. Previous studies have demonstrated that using mood stabilizers in the treatment of Alzheimer's disease is effective especially patients who show disruptive behaviors (Apostolova, 2016).
Age remains the leading risk factor for Alzheimer's disease. As one age, the functionality of the brain proteins diminishes, and this leads to the disruption of the work of the neurons in the brain cells (Klimova et al., 2015). The damage of the neurons can start an early age, but the release of the toxic events can come later at old age as in the 82-year old patient. Alzheimer's disease is not part of normal aging, even though a large proportion of the aging people experience some form of memory loss. The medications, such as cholinesterase inhibitors may help the patient by boosting the levels of communication between cells. The drug preserves the chemical messenger that is usually depleted by Alzheimer's disease.
Delegate your assignment to our experts and they will do the rest.
Dialogue
Counselor: Your condition is as a result of a combination of environmental, genetic, and lifestyle factors that affect the functionality of the brain over time.
Patient: What causes the condition?
Counselor: The condition mainly arises when the cells in the brain, known as neurons, are damaged over time, thus reducing the functionality of the brain. The damage to the brain cells may start at middle age, but permanent damage and emergence of symptoms may start at old age.
References
Klimova, B., Maresova, P., Valis, M., Hort, J., & Kuca, K. (2015). Alzheimer’s disease and language impairments: social intervention and medical treatment. Clinical interventions in aging , 10 , 1401.
Apostolova, L. G. (2016). Alzheimer disease. Continuum: Lifelong Learning in Neurology , 22 (2 Dementia), 419.
